Your browser doesn't support javascript.
loading
Antimicrobial peptides: A promising tool to combat multidrug resistance in SARS CoV2 era.
Saini, Jasleen; Kaur, Pritpal; Malik, Naveen; Lakhawat, Sudarshan Singh; Sharma, Pushpender Kumar.
Afiliação
  • Saini J; Department of Biotechnology, Sri Guru Granth Sahib World University, Fatehgarh Sahib, Punjab, India.
  • Kaur P; Department of Biotechnology, Sri Guru Granth Sahib World University, Fatehgarh Sahib, Punjab, India.
  • Malik N; Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India.
  • Lakhawat SS; Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India.
  • Sharma PK; Amity Institute of Biotechnology, Amity University Rajasthan, Jaipur, India. Electronic address: pksharma@jpr.amity.edu.
Microbiol Res ; 265: 127206, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36162150
COVID-19 (Coronavirus Disease 2019), a life-threatening viral infection, is caused by a highly pathogenic virus named SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). Currently, no treatment is available for COVID-19; hence there is an urgent need to find effective therapeutic drugs to combat COVID-19 pandemic. Considering the fact that the world is facing a major issue of antimicrobial drug resistance, naturally occurring compounds have the potential to achieve this goal. Antimicrobial peptides (AMPs) are naturally occurring antimicrobial agents which are effective against a wide variety of microbial infections. Therefore, the use of AMPs is an attractive therapeutic strategy for the treatment of SARS-CoV-2 infection. This review sheds light on the potential of antimicrobial peptides as antiviral agents followed by a comprehensive description of effective antiviral peptides derived from various natural sources found to be effective against SARS-CoV and other respiratory viruses. It also highlights the mechanisms of action of antiviral peptides with special emphasis on their effectiveness against SARS-CoV-2 infection.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: Microbiol Res Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: Microbiol Res Ano de publicação: 2022 Tipo de documento: Article